NOT KNOWN FACTUAL STATEMENTS ABOUT WELCHE DOSIS COPYRIGHT ZUM ABNEHMEN

MOUNJARO hasn't been studied in people with non-proliferative diabetic retinopathy requiring acute therapy, proliferative diabetic retinopathy, or diabetic macular edema. Sufferers with a historical past of diabetic retinopathy should be monitored for progression of diabetic retinopathy.Their efficacy and security profiles are already recognized as